Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Oncolytics Biotech Inc. ONCY

Set alert

Price alert · ONCY

All alert types
0.40 USD 0.00 -0.55%

As of Nov 3, 12:50 PM ET

Bid
0.40 × 1
Ask
0.40 × 5
0.392 Day range 0.4072
0.39 52-week range 1.30
YTD
-54.28%
1 year
-63.50%
Open
0.40
Prev close
0.40
Mkt cap
52.16M
Vol
305.51K
Avg vol
1.04M
EPS
-0.35
P/E
0.00
Div yield
0.00%
More statistics
Low
0.392
High
0.4072
Forward P/E
-3.02
Beta
1.51
Short ratio
3.51
Inst. own
1.76%
Dividend
0.00
Ex-div date
50-d avg
1.04
200-d avg
1.04
1y target
4.85

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Nov 3, 2023Earnings: -0.1; estimate -0.07; surprise -42.86%
  • Mar 7, 2024Earnings: -0.04; estimate -0.11; surprise 63.64%
  • Apr 4, 2024Rating: Raymond James · — → Outperform
  • Aug 1, 2024Earnings: -0.07; estimate -0.08; surprise 12.5%
Signals (87)
NameDateAgo
MACD: Sell SignalSep 1, 20262 months ago
SMA: BearishJul 1, 20264 months ago
SMA: BullishMay 1, 20266 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BearishMar 1, 20268 months ago
SMA: BullishFeb 1, 20269 months ago
SMA: BullishJan 1, 202610 months ago
SMA: BearishDec 1, 202511 months ago
SMA: BearishOct 1, 20251 year ago
SMA: BullishSep 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
SMA: BullishJun 1, 20251 year ago
SMA: BearishNov 1, 20242 years ago
SMA: BullishOct 1, 20242 years ago
MACD: Sell SignalJan 1, 20242 years ago
SMA: BearishOct 1, 20233 years ago
SMA: BearishOct 1, 20233 years ago
SMA: BullishJun 1, 20233 years ago
SMA: BullishApr 1, 20233 years ago
SMA: BearishMar 1, 20233 years ago

Newest 20 of 87.

Analyst view

Price target (mean) 4.85
Ratings (0m) 8 8 buy · 0 hold · 0 sell
  • Strong buy5
  • Buy3
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ONCY analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.1345-0.139 – -0.13-0.111-21.2%00.0%2
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-0.40667-0.43 – -0.38-0.489+16.8%00.0%3
Next year-0.4665-0.54 – -0.36-0.40667-14.7%857.14K0.0%4

Upgrades and downgrades

The latest rating changes

ONCY analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 21, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 4, 2024Raymond JamesInitiated—Outperform
Mar 8, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 13, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 16, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 29, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 23, 2023Canaccord GenuityReiteratedBuyBuy
Jun 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 26, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 24, 2023JonesTradingInitiated—Buy
Mar 14, 2023HC Wainwright & Co.Reiterated—Buy
Mar 6, 2023Canaccord GenuityMaintained—Buy
Oct 6, 2022Maxim GroupInitiated—Buy
Feb 17, 2021HC Wainwright & Co.Initiated—Buy
May 11, 2020RBC CapitalMaintained—Outperform
Sep 12, 2013NeedhamInitiated—Buy
Mar 4, 2013Piper SandlerInitiated—Overweight
Dec 18, 2012Bloom Burton & Co.DowngradeBuyHold
Sep 12, 2012Bloom Burton & Co.Maintained—Buy
Aug 30, 2012StifelInitiated—Buy